Scribe Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCTX and other ETFs, options, and stocks.

About SCTX

Scribe Therapeutics, Inc. is a clinical-stage biotechnology company. It is engaged in the development of in vivo therapies. 

CEO
Benjamin L. Oakes, PhD
CEOBenjamin L. Oakes, PhD
Employees
98
Employees98
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
Founded
Employees
98
Employees98

SCTX Key Statistics

Market cap
353.48M
Market cap353.48M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
132.71K
Average volume132.71K
High today
High today
Low today
Low today
Open price
$23.26
Open price$23.26
Volume
0.00
Volume0.00
52 Week high
$26.50
52 Week high$26.50
52 Week low
$15.00
52 Week low$15.00

Stock Snapshot

With a market cap of 353.48M, Scribe Therapeutics(SCTX) trades at $20.37.

Scribe Therapeutics(SCTX) stock opened on 2026-08-14 at $23.26. The price climbed to — and dipped to —.

Scribe Therapeutics(SCTX) shares are trading with a volume of 0, against a daily average of 132.71K.

In the last year, Scribe Therapeutics(SCTX) shares hit a 52-week high of $26.50 and a 52-week low of $15.00.

In the last year, Scribe Therapeutics(SCTX) shares hit a 52-week high of $26.50 and a 52-week low of $15.00.

People also own

Based on the portfolios of people who own SCTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.